Phase 1 Trials in India: Regulatory Barriers and Opportunities
Phase 1 Trials in India: Regulatory Barriers and Opportunities Navigating Regulatory Challenges and Unlocking Opportunities for Phase 1 Trials in India Introduction Phase 1 clinical trials—often referred to as first-in-human (FIH) or early-phase trials—are critical for evaluating the safety, tolerability, and pharmacokinetics of new drugs. While India has emerged as a major hub for global…
Read More “Phase 1 Trials in India: Regulatory Barriers and Opportunities” »